Results 81 to 90 of about 8,965 (175)

Mineralocorticoid receptor antagonists in heart failure with sustained monomorphic ventricular tachycardia: comparative analysis of spironolactone versus eplerenone. [PDF]

Open Heart
Szakál I, Komlósi F, Tóth P, Arnóth B, Bohus G, Vámosi P, Szegedi N, Salló Z, Osztheimer I, Perge P, Orbán G, Kardos A, Merkely B, Gellér L, Nagy KV.   +14 more
europepmc   +1 more source

Sex differences in the renal T cell profile in DOCA-salt hypertension are independent of MR activation and increases in blood pressure. [PDF]

Am J Physiol Renal Physiol
Mohamed R, Belanger KM, Moronge D, Elmarakby AA, Sullivan JC.   +4 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonist Use in Contemporary Heart Failure Care. [PDF]

Card Fail Rev
Bruno J, Mebazaa A, Moura LZ, Čelutkienė J, Sindone A, Rosano G.   +5 more
europepmc   +1 more source

Mechanisms for Mineralocorticoid-Driven Age-Related Hypertension: Potential Therapeutic Role of Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors. [PDF]

Circ Res
Golec S, Vaidya A, Pitt B, Jaffe IZ.
europepmc   +1 more source

Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of dapagliflozin and eplerenone in bulk and synthetic mixture. [PDF]

BMC Chem
Tandel P, Mehta H.
europepmc   +1 more source

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review. [PDF]

Heart Fail Rev
Van Spall HGC, Vardeny O.
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists for Liver Fibrosis: Potential Mechanisms and Research Progress. [PDF]

J Clin Transl Hepatol
Zheng H, Feng Y.
europepmc   +1 more source

Development and Optimization of an Eplerenone-Loaded Liposomal In Situ Gel for Enhanced Intranasal Delivery. [PDF]

Pharmaceutics
Baranauskaite J, Ceken I, Kubiliene A, Gerbutaviciene RJ, Türköz Acar E, Tas C.   +5 more
europepmc   +1 more source

Proteomic Profile After Intervention With Eplerenone Among Persons With HIV. [PDF]

Open Forum Infect Dis
Murthy A, Kolossváry M, Walpert AR, Sanchez E, Abohashem S, Tawakol A, Adler GK, Grinspoon SK, Srinivasa S.   +8 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. [PDF]

Int J Mol Sci
Hirai T, Katayama K.
europepmc   +1 more source